R&D

Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News | R&D

Institut Pasteur Installs Thermo Scientific Krios Cryo-TEM

Will allow structural biologists at the Institut Pasteur to extend their research in areas such as immunology & bacteriology

07.13.18

Immatics & Genmab Enter Collaboration

To develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications

07.12.18

Facilities | R&D

Jennewein Signs Lease for New R&D Center

For a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg

07.05.18

Industry News | R&D

Evotec, Sanofi Close Strategic Licensing Deal

Evotec to accelerate infectious disease research pipeline and initiate new open innovation R&D initiatives

07.03.18

Clinical Trials | Drug Development | Industry News | Information Technology | R&D

Sanofi Launches Global R&D Ops in China

New global R&D operations hub focused on digitalization and big data analysis

07.02.18

Bio News | Bioanalytical Services | Industry News | R&D

GE introduces Biacore 8K+

The eight-needle high-sensitivity surface plasmon resonance system can automate 4500 drug candidate-disease targets at once

06.18.18

Drug Development | Drug Discovery | Industry News | R&D

BridgeBio Launches CoA Therapeutics

To develop novel small-molecules designed to increase CoA levels in genetic disorders where CoA deficiency is implicated

06.14.18

APIs | Breaking News | Facilities | Industry News | R&D

Cambrex Expands Generic API R&D Capabilities

Will build new R&D lab at its Milan, Italy site

06.12.18

Drug Development | Industry News | R&D

InflaRx Opens New Research Facility

Lead candidate, IFX-1 is advancing through clinical trials with Phase IIB data in hidradenitis suppurativa expected 1H19

06.06.18

Aptar Pharma, Propeller Health Enter Collaboration

To launch a comprehensive platform to develop digital medicines for multiple therapeutic areas and diseases

05.30.18

Ipsen, University of Texas Enter Agreement

For a pre-clinical oncology drug candidate discovered by researchers in MD Anderson’s Institute for Applied Cancer Science

05.30.18

Oncternal, Pharmacyclics Enter Supply Agreement

Pharmacyclics to supply ibrutinib, a small molecule inhibitor of Bruton's tyrosine kinase (BTK), for a Phase 1b/2 trial

05.29.18

FDA Grants Krystal FTD for KB103

For the treatment of dystrophic epidermolysis bullosa (DEB)

05.24.18

Bio News | Industry News | Methods Development | R&D

Bringing A Molecule to Market

Christian Cattaruzza, Marketing Director of Bioreliance End to End Solutions at MilliporeSigma, shares insight

Videos

Avenue Announces Positive Phase 3 Trial Results

For IV tramadol, for the severe postoperative pain following surgery

05.21.18

Recipharm, Hadasit Enter Partnership

To offer combined clinical, biological and chemical services

05.15.18

Evotec AG, Carna Enter Agreement

Carna will access Evotec's INDiGO platform to accelerate the development of CB-1763, for the treatment of blood cancer

05.14.18

Drug Development | Information Technology | R&D

CRO Industry Update: Big Data Drives Drug Development Efforts

With growth in virtual trials and RWE, the clinical development landscape may never look the same

Kristin Brooks, Managing Editor 05.11.18

Moderna, Merck Expand Partnership

To continue to develop and commercialize novel personalized messenger RNA cancer vaccines

05.10.18

Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D

Protagen, UCSF Enter Collaboration

Using Protagen’s SeroTag to investigate the immuno-profiling of prostate cancer patients treated with checkpoint inhibitors